Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Coghill

Showing results (91-100 of 230) with videos related to

Pageof 23
Sort By:
JCPP Advances|September 18, 2023
Social gradient in use of health services and health-related quality of life of children with attention-deficit/hyperactivity disorder: A systematic reviewAbraham Sevastidis, Sithara Wanni Arachchige Dona, Lisa Gold, et al.
The Australian and New Zealand Journal of Psychiatry|January 19, 2021
Clinicians' perceptions of the Australian Paediatric Mental Health Service System: Problems and solutionsKate Paton, Lynn Gillam, Hayley Warren, et al.
Journal of Affective Disorders|September 3, 2020
Is 'minimally adequate treatment' really adequate? investigating the effect of mental health treatment on quality of life for children with mental health problemsJemimah Ride, Li Huang, Melissa Mulraney, et al.
European Child & Adolescent Psychiatry|December 21, 2006
Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child EditionAnne W Riley, David Coghill, Christopher B Forrest, et al.
Journal of Child and Adolescent Psychopharmacology|June 15, 2022
Can Neurocognitive Outcomes Assist Measurement-Based Care for Children with Attention-Deficit/Hyperactivity Disorder? A Systematic Review and Meta-Analyses of the Relationships Among the Changes in Neurocognitive Functions and Clinical Outcomes of Attention-Deficit/Hyperactivity Disorder in Pharmacological and Cognitive Training InterventionsSeungjae Lee, Thomas R Hill, Beth Johnson, et al.
European Child & Adolescent Psychiatry|December 21, 2006
Which factors impact on clinician-rated impairment in children with ADHD?David Coghill, Georg Spiel, Gisli Baldursson, et al.
European Child & Adolescent Psychiatry|December 21, 2006
Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European studyManfred Döpfner, Hans-Christoph Steinhausen, David Coghill, et al.
The Lancet. Psychiatry|May 25, 2019
Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder-outcome measures beyond symptom control and clinical trialsIan C K Wong, Tobias Banaschewski, Jan Buitelaar, et al.
The Australian and New Zealand Journal of Psychiatry|May 1, 2023
Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysisClaudia Bruno, Helga Zoega, Malcolm B Gillies, et al.
BMC Psychiatry|October 2, 2004
Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study dataEdmund J S Sonuga-Barke, James M Swanson, David Coghill, et al.
Pageof 23

Showing results (91-100 of 230) with videos related to

Sort By:
Pageof 23
JCPP Advances|September 18, 2023
Social gradient in use of health services and health-related quality of life of children with attention-deficit/hyperactivity disorder: A systematic reviewAbraham Sevastidis, Sithara Wanni Arachchige Dona, Lisa Gold, et al.
The Australian and New Zealand Journal of Psychiatry|January 19, 2021
Clinicians' perceptions of the Australian Paediatric Mental Health Service System: Problems and solutionsKate Paton, Lynn Gillam, Hayley Warren, et al.
Journal of Affective Disorders|September 3, 2020
Is 'minimally adequate treatment' really adequate? investigating the effect of mental health treatment on quality of life for children with mental health problemsJemimah Ride, Li Huang, Melissa Mulraney, et al.
European Child & Adolescent Psychiatry|December 21, 2006
Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child EditionAnne W Riley, David Coghill, Christopher B Forrest, et al.
Journal of Child and Adolescent Psychopharmacology|June 15, 2022
Can Neurocognitive Outcomes Assist Measurement-Based Care for Children with Attention-Deficit/Hyperactivity Disorder? A Systematic Review and Meta-Analyses of the Relationships Among the Changes in Neurocognitive Functions and Clinical Outcomes of Attention-Deficit/Hyperactivity Disorder in Pharmacological and Cognitive Training InterventionsSeungjae Lee, Thomas R Hill, Beth Johnson, et al.
European Child & Adolescent Psychiatry|December 21, 2006
Which factors impact on clinician-rated impairment in children with ADHD?David Coghill, Georg Spiel, Gisli Baldursson, et al.
European Child & Adolescent Psychiatry|December 21, 2006
Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European studyManfred Döpfner, Hans-Christoph Steinhausen, David Coghill, et al.
The Lancet. Psychiatry|May 25, 2019
Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder-outcome measures beyond symptom control and clinical trialsIan C K Wong, Tobias Banaschewski, Jan Buitelaar, et al.
The Australian and New Zealand Journal of Psychiatry|May 1, 2023
Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysisClaudia Bruno, Helga Zoega, Malcolm B Gillies, et al.
BMC Psychiatry|October 2, 2004
Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study dataEdmund J S Sonuga-Barke, James M Swanson, David Coghill, et al.
Pageof 23